GV 2019 Gp, L.P. files SEC Form 4 disclosures for Verve Therapeutics, Inc.. They have made 1 open-market trade across 1 company since 2022, most recently 2022-11-01.
CIK 0001845039
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VERV | 2,637 | $29K |
Shares reported on the most recent Form 4, priced at the 2022-11-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VERV | SELL | 2022-10-31 | 2022-11-02 | $38.30 | $5.1M | -21.5% | -28.5% | -32.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.